243 related articles for article (PubMed ID: 23183180)
21. Association between Polycystic Ovary Syndrome and Gut Microbiota.
Guo Y; Qi Y; Yang X; Zhao L; Wen S; Liu Y; Tang L
PLoS One; 2016; 11(4):e0153196. PubMed ID: 27093642
[TBL] [Abstract][Full Text] [Related]
22. Ocimum kilimandscharicum L. restores ovarian functions in letrozole - induced Polycystic Ovary Syndrome (PCOS) in rats: Comparison with metformin.
Khaled N; El-Bahy AA; Radwan R; Handoussa H; AbdelMaksoud S
Life Sci; 2019 Sep; 232():116640. PubMed ID: 31295470
[TBL] [Abstract][Full Text] [Related]
23. Effects of electro-acupuncture on ovarian P450arom, P450c17α and mRNA expression induced by letrozole in PCOS rats.
Sun J; Jin C; Wu H; Zhao J; Cui Y; Liu H; Wu L; Shi Y; Zhu B
PLoS One; 2013; 8(11):e79382. PubMed ID: 24260211
[TBL] [Abstract][Full Text] [Related]
24. Letrozole treatment of adult female mice results in a similar reproductive phenotype but distinct changes in metabolism and the gut microbiome compared to pubertal mice.
Torres PJ; Skarra DV; Ho BS; Sau L; Anvar AR; Kelley ST; Thackray VG
BMC Microbiol; 2019 Mar; 19(1):57. PubMed ID: 30871463
[TBL] [Abstract][Full Text] [Related]
25. Hyperandrogenemia Induced by Letrozole Treatment of Pubertal Female Mice Results in Hyperinsulinemia Prior to Weight Gain and Insulin Resistance.
Skarra DV; Hernández-Carretero A; Rivera AJ; Anvar AR; Thackray VG
Endocrinology; 2017 Sep; 158(9):2988-3003. PubMed ID: 28911175
[TBL] [Abstract][Full Text] [Related]
26. Functional investigation on aromatase in endometrial hyperplasia in polycystic ovary syndrome cases.
Zhao PL; Zhang QF; Yan LY; Huang S; Chen Y; Qiao J
Asian Pac J Cancer Prev; 2014; 15(20):8975-9. PubMed ID: 25374239
[TBL] [Abstract][Full Text] [Related]
27. Use of the aromatase inhibitor letrozole for ovulation induction in women with polycystic ovarian syndrome.
Casper RF; Mitwally MF
Clin Obstet Gynecol; 2011 Dec; 54(4):685-95. PubMed ID: 22031258
[TBL] [Abstract][Full Text] [Related]
28. The promising effect of linagliptin and/or indole-3-carbinol on experimentally-induced polycystic ovarian syndrome.
Kabel AM; Al-Shehri AH; Al-Talhi RA; Abd Elmaaboud MA
Chem Biol Interact; 2017 Aug; 273():190-199. PubMed ID: 28619389
[TBL] [Abstract][Full Text] [Related]
29. [Study on the oxidative stress in the ovaries of a rat model of polycystic ovary].
Gong J; Wu DB; Zhang LL; Li J; Zhao X; Zhang D
Sichuan Da Xue Xue Bao Yi Xue Ban; 2015 Mar; 46(2):238-42, 247. PubMed ID: 25924437
[TBL] [Abstract][Full Text] [Related]
30. Dual targeting of TNF-α and free radical toxic stress as a promising strategy to manage experimental polycystic ovary.
Rezvanfar MA; Saeedi S; Mansoori P; Saadat S; Goosheh M; Shojaei Saadi HA; Baeeri M; Abdollahi M
Pharm Biol; 2016; 54(1):80-90. PubMed ID: 25955958
[TBL] [Abstract][Full Text] [Related]
31. The significant improvement in ovarian PCOS syndrome using hydralazine and alendronate aromatase inhibitor FDA-approved drugs in Wistar rat models.
Kavousipour S; Koohnavard F; Shahbazi B; Eftekhar E; Ahmadi K
Biomed Pharmacother; 2024 May; 174():116504. PubMed ID: 38552442
[TBL] [Abstract][Full Text] [Related]
32. Insulin Sensitizers Modulate GnRH Receptor Expression in PCOS Rats.
Patel R; Shah G
Arch Med Res; 2018 Apr; 49(3):154-163. PubMed ID: 30104075
[TBL] [Abstract][Full Text] [Related]
33. Effects of Metformin on Reproductive, Endocrine, and Metabolic Characteristics of Female Offspring in a Rat Model of Letrozole-Induced Polycystic Ovarian Syndrome With Insulin Resistance.
Xie Y; Xiao L; Li S
Front Endocrinol (Lausanne); 2021; 12():701590. PubMed ID: 34484117
[TBL] [Abstract][Full Text] [Related]
34. Pathophysiological changes in experimental polycystic ovary syndrome in female albino rats: Using either hemin or L-arginine.
Ragy MM; Abdel-Hamid HA; Toni NDM
J Cell Physiol; 2019 Jun; 234(6):8426-8435. PubMed ID: 30443939
[TBL] [Abstract][Full Text] [Related]
35. Effects of suppression of estrogen action by the p450 aromatase inhibitor letrozole on bone mineral density and bone turnover in pubertal boys.
Wickman S; Kajantie E; Dunkel L
J Clin Endocrinol Metab; 2003 Aug; 88(8):3785-93. PubMed ID: 12915670
[TBL] [Abstract][Full Text] [Related]
36. Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam's criteria and women whose only clinical signs are oligo/anovulation or hirsutism.
Hassa H; Tanir HM; Yildiz Z
Arch Gynecol Obstet; 2006 Jul; 274(4):227-32. PubMed ID: 16691383
[TBL] [Abstract][Full Text] [Related]
37. Ameliorative effects of fisetin in letrozole-induced rat model of polycystic ovary syndrome.
Mihanfar A; Nouri M; Roshangar L; Khadem-Ansari MH
J Steroid Biochem Mol Biol; 2021 Oct; 213():105954. PubMed ID: 34298098
[TBL] [Abstract][Full Text] [Related]
38. Efficacy of combined metformin-letrozole in comparison with bilateral ovarian drilling in clomiphene-resistant infertile women with polycystic ovarian syndrome.
Abd Elgafor I
Arch Gynecol Obstet; 2013 Jul; 288(1):119-23. PubMed ID: 23361456
[TBL] [Abstract][Full Text] [Related]
39. Effects of letrozole on hippocampal and cortical catecholaminergic neurotransmitter levels, neural cell adhesion molecule expression and spatial learning and memory in female rats.
Aydin M; Yilmaz B; Alcin E; Nedzvetsky VS; Sahin Z; Tuzcu M
Neuroscience; 2008 Jan; 151(1):186-94. PubMed ID: 18061360
[TBL] [Abstract][Full Text] [Related]
40. Low dose spironolactone-mediated androgen-adiponectin modulation alleviates endocrine-metabolic disturbances in letrozole-induced PCOS.
Olaniyi KS; Oniyide AA; Adeyanju OA; Ojulari LS; Omoaghe AO; Olaiya OE
Toxicol Appl Pharmacol; 2021 Jan; 411():115381. PubMed ID: 33359182
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
